An analysis of adjuvant treatment strategies for carcinoma of the cervix

R. A. Potish, L. B. Twiggs

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The majority of women with cancer of the cervix are cured with radiation or surgery, but a sizable fraction of tumors recur. Adjuvant chemotherapy is generally toxic and of limited efficacy. Thus 49 women with surgical staging and estrogen and progesterone receptors were analyzed with logistic models to identify patients at high and low risk of treatment failure following conventional therapy. This methodology allows the patient and her physician to optimize choice of therapy. The benefits and limitations of such a decision theory analysis are discussed.

Original languageEnglish
Pages (from-to)430-433
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume12
Issue number5
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Cervix Uteri
Decision Theory
Carcinoma
Decision Support Techniques
Poisons
Progesterone Receptors
Adjuvant Chemotherapy
Treatment Failure
Uterine Cervical Neoplasms
Estrogen Receptors
Logistic Models
Radiation
Physicians
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

An analysis of adjuvant treatment strategies for carcinoma of the cervix. / Potish, R. A.; Twiggs, L. B.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 12, No. 5, 01.01.1989, p. 430-433.

Research output: Contribution to journalArticle

@article{8c7227be10aa47b5a242409eba535a84,
title = "An analysis of adjuvant treatment strategies for carcinoma of the cervix",
abstract = "The majority of women with cancer of the cervix are cured with radiation or surgery, but a sizable fraction of tumors recur. Adjuvant chemotherapy is generally toxic and of limited efficacy. Thus 49 women with surgical staging and estrogen and progesterone receptors were analyzed with logistic models to identify patients at high and low risk of treatment failure following conventional therapy. This methodology allows the patient and her physician to optimize choice of therapy. The benefits and limitations of such a decision theory analysis are discussed.",
author = "Potish, {R. A.} and Twiggs, {L. B.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "12",
pages = "430--433",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - An analysis of adjuvant treatment strategies for carcinoma of the cervix

AU - Potish, R. A.

AU - Twiggs, L. B.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The majority of women with cancer of the cervix are cured with radiation or surgery, but a sizable fraction of tumors recur. Adjuvant chemotherapy is generally toxic and of limited efficacy. Thus 49 women with surgical staging and estrogen and progesterone receptors were analyzed with logistic models to identify patients at high and low risk of treatment failure following conventional therapy. This methodology allows the patient and her physician to optimize choice of therapy. The benefits and limitations of such a decision theory analysis are discussed.

AB - The majority of women with cancer of the cervix are cured with radiation or surgery, but a sizable fraction of tumors recur. Adjuvant chemotherapy is generally toxic and of limited efficacy. Thus 49 women with surgical staging and estrogen and progesterone receptors were analyzed with logistic models to identify patients at high and low risk of treatment failure following conventional therapy. This methodology allows the patient and her physician to optimize choice of therapy. The benefits and limitations of such a decision theory analysis are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024447501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024447501&partnerID=8YFLogxK

M3 - Article

C2 - 2801604

AN - SCOPUS:0024447501

VL - 12

SP - 430

EP - 433

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 5

ER -